257 related articles for article (PubMed ID: 11864800)
1. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.
Cella D; Eton DT; Fairclough DL; Bonomi P; Heyes AE; Silberman C; Wolf MK; Johnson DH
J Clin Epidemiol; 2002 Mar; 55(3):285-95. PubMed ID: 11864800
[TBL] [Abstract][Full Text] [Related]
2. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).
Thongprasert S; Duffield E; Saijo N; Wu YL; Yang JC; Chu DT; Liao M; Chen YM; Kuo HP; Negoro S; Lam KC; Armour A; Magill P; Fukuoka M
J Thorac Oncol; 2011 Nov; 6(11):1872-80. PubMed ID: 22011650
[TBL] [Abstract][Full Text] [Related]
6. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
Eton DT; Fairclough DL; Cella D; Yount SE; Bonomi P; Johnson DH;
J Clin Oncol; 2003 Apr; 21(8):1536-43. PubMed ID: 12697878
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.
Sekine I; Ichinose Y; Nishiwaki Y; Yamamoto N; Tsuboi M; Nakagawa K; Shinkai T; Negoro S; Imamura F; Eguchi K; Takeda K; Itoh Y; Tamura T; Saijo N; Fukuoka M
Ann Oncol; 2009 Sep; 20(9):1483-1488. PubMed ID: 19282468
[TBL] [Abstract][Full Text] [Related]
8. Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: post hoc analyses from the IPASS study.
Wu YL; Fukuoka M; Mok TS; Saijo N; Thongprasert S; Yang JC; Chu DT; Yang JJ; Rukazenkov Y
Lung Cancer; 2013 Aug; 81(2):280-7. PubMed ID: 23540718
[TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.
Cella DF; Bonomi AE; Lloyd SR; Tulsky DS; Kaplan E; Bonomi P
Lung Cancer; 1995 Jun; 12(3):199-220. PubMed ID: 7655830
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effects of health-related quality of life at baseline and early change in health-related quality of life on response to treatment and survival in patients with advanced lung cancer: a prospective observational study in China.
Liu J; Ma Y; Gao R; Liu X; Wang Y; Yu J; Zhan J; Huang Y; Qin H; Zhang L
BMJ Open; 2022 Feb; 12(2):e047611. PubMed ID: 35165103
[TBL] [Abstract][Full Text] [Related]
11. Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
Cella D; Herbst RS; Lynch TJ; Prager D; Belani CP; Schiller JH; Heyes A; Ochs JS; Wolf MK; Kay AC; Kris MG; Natale RB
J Clin Oncol; 2005 May; 23(13):2946-54. PubMed ID: 15699477
[TBL] [Abstract][Full Text] [Related]
12. Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors.
LoRusso PM; Herbst RS; Rischin D; Ranson M; Calvert H; Raymond E; Kieback D; Kaye S; Gianni L; Harris A; Bjork T; Maddox AM; Rothenberg ML; Small EJ; Rubin EH; Feyereislova A; Heyes A; Averbuch SD; Ochs J; Baselga J
Clin Cancer Res; 2003 Jun; 9(6):2040-8. PubMed ID: 12796366
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Lung Cancer Subscale in older patients with advanced non-small cell lung cancer: An integrated analysis of JCOG0207 and JCOG0803/WJOG4307L (JCOG1414A).
Mizutani T; Ando M; Mizusawa J; Nakamura K; Fukuda H; Tsukada H; Abe T; Takeda K; Yokoyama A; Nakamura S; Nakagawa K; Yamamoto N; Ohe Y
J Geriatr Oncol; 2018 Nov; 9(6):583-588. PubMed ID: 29731344
[TBL] [Abstract][Full Text] [Related]
14. QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC.
Yang YP; Ma YX; Huang Y; Zhao YY; Fang WF; Hong SD; Tian Y; Xue C; Sheng J; Zhang L
Sci Rep; 2015 Jul; 5():11934. PubMed ID: 26137916
[TBL] [Abstract][Full Text] [Related]
15. Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Spigel DR; Patel JD; Reynolds CH; Garon EB; Hermann RC; Govindan R; Olsen MR; Winfree KB; Chen J; Liu J; Guba SC; Socinski MA; Bonomi P
J Thorac Oncol; 2015 Feb; 10(2):353-9. PubMed ID: 25611228
[TBL] [Abstract][Full Text] [Related]
16. Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale.
Cella D
Semin Oncol; 2003 Feb; 30(1 Suppl 1):39-48. PubMed ID: 12644983
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
18. Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.
Phippen NT; Secord AA; Wolf S; Samsa G; Davidson B; Abernethy AP; Cella D; Havrilesky LJ; Burger RA; Monk BJ; Leath CA
Gynecol Oncol; 2017 Oct; 147(1):98-103. PubMed ID: 28743369
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical Procedures.
Raz DJ; Sun V; Kim JY; Williams AC; Koczywas M; Cristea M; Reckamp K; Hayter J; Tiep B; Ferrell B
Ann Thorac Surg; 2016 Feb; 101(2):495-502; discussion 502-3. PubMed ID: 26443881
[TBL] [Abstract][Full Text] [Related]
20. Effect of Wellness Education on Quality of Life of Patients With Non-Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers.
Li Y; Ling L; Zhanyu P
Integr Cancer Ther; 2019; 18():1534735419842373. PubMed ID: 31043093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
